Global Clinical Trial Imaging Supply, Demand and Key Producers, 2025-2031
Page: 141
Published Date: 5 Jul 2025
Category: Service & Software
PDF Download
Get FREE Sample
Customize Request
Description 
Table of Contents 
Table of Figures 
Research Methodology 
Companies Mentioned 
Related Reports 
Product Tags
Table of Contents 
Table of Figures 
Research Methodology 
Companies Mentioned 
Related Reports 
Product Tags 
Description
The global Clinical Trial Imaging market size is expected to reach $ 2550 million by 2031, rising at a market growth of 6.8% CAGR during the forecast period (2025-2031).
Clinical trial imaging refers to the process of using imaging technology (such as X-ray, CT, MRI, etc.) to observe and analyze the subjects in vivo during clinical trials. It plays an irreplaceable role in evaluating the efficacy, safety and side effects of new drugs, treatments or medical devices. Through imaging technology, researchers can intuitively observe the distribution, metabolism and mechanism of action of drugs in the body, providing a scientific basis for the clinical application of drugs.
Clinical Trial Imaging
The global Clinical Trial Imaging market size is expected to reach $ 2550 million by 2031, rising at a market growth of 6.8% CAGR during the forecast period (2025-2031).
Unit: US$ M
www.globalinforesearch.com
Business Risk & Industry Analysis Reports
The core manufacturers of clinical trial imaging in the world include Clario, ICON, McLaren, Calyx and BioTelemetry. The top five companies hold about 60% of the shares. North America is the largest market, with a share of about 33%, followed by Europe and Asia Pacific, each with a share of about 27%. In terms of product type, central imaging services are the largest market segment, with a share of about 70%. In terms of application, the largest application is pharmaceutical companies, followed by biotechnology companies.
In the process of clinical trial imaging, ethical principles and regulatory requirements must be strictly followed. Researchers need to ensure that the informed consent rights of subjects are fully guaranteed and that scientific principles and ethical standards are strictly followed during the trial. At the same time, regulatory agencies also need to strengthen the supervision of clinical trial imaging to ensure the reliability and validity of trial results.
Clinical trial imaging plays an important role in different stages of drug development. For example, in Phase I clinical trials, imaging technology can be used to observe the pharmacokinetic characteristics of drugs in the human body; in Phase II/III clinical trials, the efficacy and safety of drugs can be evaluated.
For new medical devices, clinical trial imaging can be used to evaluate their performance, safety and clinical application value. By comparing the effects of using new equipment with existing equipment, strong support can be provided for the promotion and application of medical equipment.
In clinical trials, imaging technology can also be used for early diagnosis of diseases, disease monitoring and evaluation of treatment effects. For example, in tumor treatment, regular imaging examinations can be used to observe the size, morphology and changes of tumors, so as to adjust the treatment plan in time.
With the continuous advancement of medical technology and the increasing demand for clinical trials, the clinical trial imaging market will usher in a broader development prospect. In the future, this field will pay more attention to the development of technological innovation and personalized services to meet the needs of different clinical trials.
The driving factors of the clinical trial imaging market mainly include the following:
Technological progress: innovation drives core growth
High-precision and multimodal imaging technology
Breakthroughs in technologies such as MRI, CT, and PET: High-resolution imaging technology (such as 3T MRI and ultra-low-dose CT) provides more accurate anatomical and functional information, which helps early diagnosis of diseases and efficacy evaluation.
Multimodal fusion: The fusion technology of CT and MRI, PET and CT, combined with anatomical and metabolic information, significantly improves diagnostic sensitivity, such as in tumor staging.
Artificial Intelligence and Automation
AI-assisted analysis: Deep learning algorithms can automatically detect lesions (such as lung nodules and breast calcifications), reduce human errors, and improve diagnostic efficiency.
Process Automation: AI optimizes scanning protocols and automatically generates reports, shortens clinical trial cycles, and reduces costs.
Portable and Real-time Imaging
Portable ultrasound equipment: Suitable for bedside examinations and remote areas, expanding the coverage of clinical trials.
Real-time imaging technology: such as ultrasound elastic imaging, dynamically monitors changes in tissue hardness, and provides instant feedback for diseases such as liver fibrosis.
Policy support: Create a favorable development environment
Improvement of regulatory framework
FDA, NMPA and other agencies: Ensure the safety and effectiveness of equipment through strict approval processes, such as requiring that Class III medical imaging equipment must pass clinical trials before registration.
International Standard Coordination: Promote imaging protocols and data standardization (such as DICOM format) and promote multi-center trial data sharing.
Funding and Incentives
Government research funding: For example, China's "14th Five-Year Plan" special support for medical imaging technology to accelerate technology transformation.
Tax incentives and subsidies: Encourage corporate R&D and innovation, such as providing financial subsidies for localization projects of high-end imaging equipment.
Growth in medical demand: changes in population and disease structure
Aging and chronic disease burden
High incidence of cancer and neurodegenerative diseases: The global incidence of cancer is rising, driving the demand for early screening and efficacy monitoring.
Demand for precision medicine: Individualized treatment relies on high-precision imaging (such as molecular imaging in tumor targeted therapy).
New drug development and clinical trial expansion
Innovative drug development boom: The number of new drugs under development has surged globally, and the demand for imaging in clinical trials has increased accordingly.
Rare diseases and real-world research: Imaging technology helps small sample size trials and long-term efficacy tracking.
The growth of the clinical trial imaging market is the result of technological innovation, policy dividends, demand upgrades and the evolution of the competitive landscape. In the future, with the deep integration of AI, multimodal imaging and cloud technology, the market will accelerate its development towards intelligence and precision. At the same time, the rise of local companies will reshape the global competitive landscape and inject new vitality into the industry.
This report studies the global Clinical Trial Imaging demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Clinical Trial Imaging, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2024 as the base year. This report explores demand trends and competition, as well as details the characteristics of Clinical Trial Imaging that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Clinical Trial Imaging total market, 2020-2031, (USD Million)
Global Clinical Trial Imaging total market by region & country, CAGR, 2020-2031, (USD Million)
U.S. VS China: Clinical Trial Imaging total market, key domestic companies, and share, (USD Million)
Global Clinical Trial Imaging revenue by player, revenue and market share 2020-2025, (USD Million)
Global Clinical Trial Imaging total market by Type, CAGR, 2020-2031, (USD Million)
Global Clinical Trial Imaging total market by Application, CAGR, 2020-2031, (USD Million)
This report profiles major players in the global Clinical Trial Imaging market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ICON, ERT, McLaren, Bioclinica, Parexel, BioTelemetry, ProScan Imaging, Imaging Endpoints, Radiant Sage, Micron, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Clinical Trial Imaging market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2020-2031 by year with 2024 as the base year, 2025 as the estimate year, and 2026-2031 as the forecast year.
Global Clinical Trial Imaging Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Clinical Trial Imaging Market, Segmentation by Type
In-house Imaging Service
Central Imaging Service
Global Clinical Trial Imaging Market, Segmentation by Application:
Pharmaceutical Companies
Biotechnology Companies
Academic Institutes
Others
Companies Profiled:
ICON
ERT
McLaren
Bioclinica
Parexel
BioTelemetry
ProScan Imaging
Imaging Endpoints
Radiant Sage
Micron, Inc.
Intrinsic Imaging
Median Technologies
Cardiovascular Imaging Technologies
Banook Medical
IXICO
Tigermed
Runda Medical
Konica Minolta
Keosys
Key Questions Answered
1. How big is the global Clinical Trial Imaging market?
2. What is the demand of the global Clinical Trial Imaging market?
3. What is the year over year growth of the global Clinical Trial Imaging market?
4. What is the total value of the global Clinical Trial Imaging market?
5. Who are the Major Players in the global Clinical Trial Imaging market?
6. What are the growth factors driving the market demand?
Table of Contents
1 Supply Summary
1.1 Clinical Trial Imaging Introduction
1.2 World Clinical Trial Imaging Market Size & Forecast (2020 & 2024 & 2031)
1.3 World Clinical Trial Imaging Total Market by Region (by Headquarter Location)
1.3.1 World Clinical Trial Imaging Market Size by Region (2020-2031), (by Headquarter Location)
1.3.2 United States Based Company Clinical Trial Imaging Revenue (2020-2031)
1.3.3 China Based Company Clinical Trial Imaging Revenue (2020-2031)
1.3.4 Europe Based Company Clinical Trial Imaging Revenue (2020-2031)
1.3.5 Japan Based Company Clinical Trial Imaging Revenue (2020-2031)
1.3.6 South Korea Based Company Clinical Trial Imaging Revenue (2020-2031)
1.3.7 ASEAN Based Company Clinical Trial Imaging Revenue (2020-2031)
1.3.8 India Based Company Clinical Trial Imaging Revenue (2020-2031)
1.4 Market Drivers, Restraints and Trends
1.4.1 Clinical Trial Imaging Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2.1 World Clinical Trial Imaging Consumption Value (2020-2031)
2.2 World Clinical Trial Imaging Consumption Value by Region
2.2.1 World Clinical Trial Imaging Consumption Value by Region (2020-2025)
2.2.2 World Clinical Trial Imaging Consumption Value Forecast by Region (2026-2031)
2.3 United States Clinical Trial Imaging Consumption Value (2020-2031)
2.4 China Clinical Trial Imaging Consumption Value (2020-2031)
2.5 Europe Clinical Trial Imaging Consumption Value (2020-2031)
2.6 Japan Clinical Trial Imaging Consumption Value (2020-2031)
2.7 South Korea Clinical Trial Imaging Consumption Value (2020-2031)
2.8 ASEAN Clinical Trial Imaging Consumption Value (2020-2031)
2.9 India Clinical Trial Imaging Consumption Value (2020-2031)
3.1 World Clinical Trial Imaging Revenue by Player (2020-2025)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Clinical Trial Imaging Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Clinical Trial Imaging in 2024
3.2.3 Global Concentration Ratios (CR8) for Clinical Trial Imaging in 2024
3.3 Clinical Trial Imaging Company Evaluation Quadrant
3.4 Clinical Trial Imaging Market: Overall Company Footprint Analysis
3.4.1 Clinical Trial Imaging Market: Region Footprint
3.4.2 Clinical Trial Imaging Market: Company Product Type Footprint
3.4.3 Clinical Trial Imaging Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4.1 United States VS China: Clinical Trial Imaging Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Clinical Trial Imaging Revenue Comparison (2020 & 2024 & 2031) (by Headquarter Location)
4.1.2 United States VS China: Clinical Trial Imaging Revenue Market Share Comparison (2020 & 2024 & 2031)
4.2 United States Based Companies VS China Based Companies: Clinical Trial Imaging Consumption Value Comparison
4.2.1 United States VS China: Clinical Trial Imaging Consumption Value Comparison (2020 & 2024 & 2031)
4.2.2 United States VS China: Clinical Trial Imaging Consumption Value Market Share Comparison (2020 & 2024 & 2031)
4.3 United States Based Clinical Trial Imaging Companies and Market Share, 2020-2025
4.3.1 United States Based Clinical Trial Imaging Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Clinical Trial Imaging Revenue, (2020-2025)
4.4 China Based Companies Clinical Trial Imaging Revenue and Market Share, 2020-2025
4.4.1 China Based Clinical Trial Imaging Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Clinical Trial Imaging Revenue, (2020-2025)
4.5 Rest of World Based Clinical Trial Imaging Companies and Market Share, 2020-2025
4.5.1 Rest of World Based Clinical Trial Imaging Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Clinical Trial Imaging Revenue (2020-2025)
5.1 World Clinical Trial Imaging Market Size Overview by Type: 2020 VS 2024 VS 2031
5.2 Segment Introduction by Type
5.2.1 In-house Imaging Service
5.2.2 Central Imaging Service
5.3 Market Segment by Type
5.3.1 World Clinical Trial Imaging Market Size by Type (2020-2025)
5.3.2 World Clinical Trial Imaging Market Size by Type (2026-2031)
5.3.3 World Clinical Trial Imaging Market Size Market Share by Type (2026-2031)
6.1 World Clinical Trial Imaging Market Size Overview by Application: 2020 VS 2024 VS 2031
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical Companies
6.2.2 Biotechnology Companies
6.2.3 Academic Institutes
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Clinical Trial Imaging Market Size by Application (2020-2025)
6.3.2 World Clinical Trial Imaging Market Size by Application (2026-2031)
6.3.3 World Clinical Trial Imaging Market Size Market Share by Application (2020-2031)
7.1 ICON
7.1.1 ICON Details
7.1.2 ICON Major Business
7.1.3 ICON Clinical Trial Imaging Product and Services
7.1.4 ICON Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
7.1.5 ICON Recent Developments/Updates
7.1.6 ICON Competitive Strengths & Weaknesses
7.2 ERT
7.2.1 ERT Details
7.2.2 ERT Major Business
7.2.3 ERT Clinical Trial Imaging Product and Services
7.2.4 ERT Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
7.2.5 ERT Recent Developments/Updates
7.2.6 ERT Competitive Strengths & Weaknesses
7.3 McLaren
7.3.1 McLaren Details
7.3.2 McLaren Major Business
7.3.3 McLaren Clinical Trial Imaging Product and Services
7.3.4 McLaren Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
7.3.5 McLaren Recent Developments/Updates
7.3.6 McLaren Competitive Strengths & Weaknesses
7.4 Bioclinica
7.4.1 Bioclinica Details
7.4.2 Bioclinica Major Business
7.4.3 Bioclinica Clinical Trial Imaging Product and Services
7.4.4 Bioclinica Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
7.4.5 Bioclinica Recent Developments/Updates
7.4.6 Bioclinica Competitive Strengths & Weaknesses
7.5 Parexel
7.5.1 Parexel Details
7.5.2 Parexel Major Business
7.5.3 Parexel Clinical Trial Imaging Product and Services
7.5.4 Parexel Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
7.5.5 Parexel Recent Developments/Updates
7.5.6 Parexel Competitive Strengths & Weaknesses
7.6 BioTelemetry
7.6.1 BioTelemetry Details
7.6.2 BioTelemetry Major Business
7.6.3 BioTelemetry Clinical Trial Imaging Product and Services
7.6.4 BioTelemetry Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
7.6.5 BioTelemetry Recent Developments/Updates
7.6.6 BioTelemetry Competitive Strengths & Weaknesses
7.7 ProScan Imaging
7.7.1 ProScan Imaging Details
7.7.2 ProScan Imaging Major Business
7.7.3 ProScan Imaging Clinical Trial Imaging Product and Services
7.7.4 ProScan Imaging Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
7.7.5 ProScan Imaging Recent Developments/Updates
7.7.6 ProScan Imaging Competitive Strengths & Weaknesses
7.8 Imaging Endpoints
7.8.1 Imaging Endpoints Details
7.8.2 Imaging Endpoints Major Business
7.8.3 Imaging Endpoints Clinical Trial Imaging Product and Services
7.8.4 Imaging Endpoints Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
7.8.5 Imaging Endpoints Recent Developments/Updates
7.8.6 Imaging Endpoints Competitive Strengths & Weaknesses
7.9 Radiant Sage
7.9.1 Radiant Sage Details
7.9.2 Radiant Sage Major Business
7.9.3 Radiant Sage Clinical Trial Imaging Product and Services
7.9.4 Radiant Sage Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
7.9.5 Radiant Sage Recent Developments/Updates
7.9.6 Radiant Sage Competitive Strengths & Weaknesses
7.10 Micron, Inc.
7.10.1 Micron, Inc. Details
7.10.2 Micron, Inc. Major Business
7.10.3 Micron, Inc. Clinical Trial Imaging Product and Services
7.10.4 Micron, Inc. Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
7.10.5 Micron, Inc. Recent Developments/Updates
7.10.6 Micron, Inc. Competitive Strengths & Weaknesses
7.11 Intrinsic Imaging
7.11.1 Intrinsic Imaging Details
7.11.2 Intrinsic Imaging Major Business
7.11.3 Intrinsic Imaging Clinical Trial Imaging Product and Services
7.11.4 Intrinsic Imaging Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
7.11.5 Intrinsic Imaging Recent Developments/Updates
7.11.6 Intrinsic Imaging Competitive Strengths & Weaknesses
7.12 Median Technologies
7.12.1 Median Technologies Details
7.12.2 Median Technologies Major Business
7.12.3 Median Technologies Clinical Trial Imaging Product and Services
7.12.4 Median Technologies Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
7.12.5 Median Technologies Recent Developments/Updates
7.12.6 Median Technologies Competitive Strengths & Weaknesses
7.13 Cardiovascular Imaging Technologies
7.13.1 Cardiovascular Imaging Technologies Details
7.13.2 Cardiovascular Imaging Technologies Major Business
7.13.3 Cardiovascular Imaging Technologies Clinical Trial Imaging Product and Services
7.13.4 Cardiovascular Imaging Technologies Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
7.13.5 Cardiovascular Imaging Technologies Recent Developments/Updates
7.13.6 Cardiovascular Imaging Technologies Competitive Strengths & Weaknesses
7.14 Banook Medical
7.14.1 Banook Medical Details
7.14.2 Banook Medical Major Business
7.14.3 Banook Medical Clinical Trial Imaging Product and Services
7.14.4 Banook Medical Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
7.14.5 Banook Medical Recent Developments/Updates
7.14.6 Banook Medical Competitive Strengths & Weaknesses
7.15 IXICO
7.15.1 IXICO Details
7.15.2 IXICO Major Business
7.15.3 IXICO Clinical Trial Imaging Product and Services
7.15.4 IXICO Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
7.15.5 IXICO Recent Developments/Updates
7.15.6 IXICO Competitive Strengths & Weaknesses
7.16 Tigermed
7.16.1 Tigermed Details
7.16.2 Tigermed Major Business
7.16.3 Tigermed Clinical Trial Imaging Product and Services
7.16.4 Tigermed Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
7.16.5 Tigermed Recent Developments/Updates
7.16.6 Tigermed Competitive Strengths & Weaknesses
7.17 Runda Medical
7.17.1 Runda Medical Details
7.17.2 Runda Medical Major Business
7.17.3 Runda Medical Clinical Trial Imaging Product and Services
7.17.4 Runda Medical Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
7.17.5 Runda Medical Recent Developments/Updates
7.17.6 Runda Medical Competitive Strengths & Weaknesses
7.18 Konica Minolta
7.18.1 Konica Minolta Details
7.18.2 Konica Minolta Major Business
7.18.3 Konica Minolta Clinical Trial Imaging Product and Services
7.18.4 Konica Minolta Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
7.18.5 Konica Minolta Recent Developments/Updates
7.18.6 Konica Minolta Competitive Strengths & Weaknesses
7.19 Keosys
7.19.1 Keosys Details
7.19.2 Keosys Major Business
7.19.3 Keosys Clinical Trial Imaging Product and Services
7.19.4 Keosys Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
7.19.5 Keosys Recent Developments/Updates
7.19.6 Keosys Competitive Strengths & Weaknesses
8.1 Clinical Trial Imaging Industry Chain
8.2 Clinical Trial Imaging Upstream Analysis
8.3 Clinical Trial Imaging Midstream Analysis
8.4 Clinical Trial Imaging Downstream Analysis
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables Table 1. World Clinical Trial Imaging Revenue by Region (2020, 2024 and 2031) & (USD Million), (by Headquarter Location) Table 2. World Clinical Trial Imaging Revenue by Region (2020-2025) & (USD Million), (by Headquarter Location) Table 3. World Clinical Trial Imaging Revenue by Region (2026-2031) & (USD Million), (by Headquarter Location) Table 4. World Clinical Trial Imaging Revenue Market Share by Region (2020-2025), (by Headquarter Location) Table 5. World Clinical Trial Imaging Revenue Market Share by Region (2026-2031), (by Headquarter Location) Table 6. Major Market Trends Table 7. World Clinical Trial Imaging Consumption Value Growth Rate Forecast by Region (2020 & 2024 & 2031) & (USD Million) Table 8. World Clinical Trial Imaging Consumption Value by Region (2020-2025) & (USD Million) Table 9. World Clinical Trial Imaging Consumption Value Forecast by Region (2026-2031) & (USD Million) Table 10. World Clinical Trial Imaging Revenue by Player (2020-2025) & (USD Million) Table 11. Revenue Market Share of Key Clinical Trial Imaging Players in 2024 Table 12. World Clinical Trial Imaging Industry Rank of Major Player, Based on Revenue in 2024 Table 13. Global Clinical Trial Imaging Company Evaluation Quadrant Table 14. Head Office of Key Clinical Trial Imaging Players Table 15. Clinical Trial Imaging Market: Company Product Type Footprint Table 16. Clinical Trial Imaging Market: Company Product Application Footprint Table 17. Clinical Trial Imaging Mergers & Acquisitions Activity Table 18. United States VS China Clinical Trial Imaging Revenue Comparison, (2020 & 2024 & 2031) & (USD Million) Table 19. United States VS China Clinical Trial Imaging Consumption Value Comparison, (2020 & 2024 & 2031) & (USD Million) Table 20. United States Based Clinical Trial Imaging Companies, Headquarters (States, Country) Table 21. United States Based Companies Clinical Trial Imaging Revenue, (2020-2025) & (USD Million) Table 22. United States Based Companies Clinical Trial Imaging Revenue Market Share (2020-2025) Table 23. China Based Clinical Trial Imaging Companies, Headquarters (Province, Country) Table 24. China Based Companies Clinical Trial Imaging Revenue, (2020-2025) & (USD Million) Table 25. China Based Companies Clinical Trial Imaging Revenue Market Share (2020-2025) Table 26. Rest of World Based Clinical Trial Imaging Companies, Headquarters (Province, Country) Table 27. Rest of World Based Companies Clinical Trial Imaging Revenue (2020-2025) & (USD Million) Table 28. Rest of World Based Companies Clinical Trial Imaging Revenue Market Share (2020-2025) Table 29. World Clinical Trial Imaging Market Size by Type, (USD Million), 2020 & 2024 & 2031 Table 30. World Clinical Trial Imaging Market Size Value by Type (2020-2025) & (USD Million) Table 31. World Clinical Trial Imaging Market Size by Type (2026-2031) & (USD Million) Table 32. World Clinical Trial Imaging Market Size by Application, (USD Million), 2020 & 2024 & 2031 Table 33. World Clinical Trial Imaging Market Size by Application (2020-2025) & (USD Million) Table 34. World Clinical Trial Imaging Market Size by Application (2026-2031) & (USD Million) Table 35. ICON Basic Information, Manufacturing Base and Competitors Table 36. ICON Major Business Table 37. ICON Clinical Trial Imaging Product and Services Table 38. ICON Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025) & (USD Million) Table 39. ICON Recent Developments/Updates Table 40. ICON Competitive Strengths & Weaknesses Table 41. ERT Basic Information, Manufacturing Base and Competitors Table 42. ERT Major Business Table 43. ERT Clinical Trial Imaging Product and Services Table 44. ERT Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025) & (USD Million) Table 45. ERT Recent Developments/Updates Table 46. ERT Competitive Strengths & Weaknesses Table 47. McLaren Basic Information, Manufacturing Base and Competitors Table 48. McLaren Major Business Table 49. McLaren Clinical Trial Imaging Product and Services Table 50. McLaren Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025) & (USD Million) Table 51. McLaren Recent Developments/Updates Table 52. McLaren Competitive Strengths & Weaknesses Table 53. Bioclinica Basic Information, Manufacturing Base and Competitors Table 54. Bioclinica Major Business Table 55. Bioclinica Clinical Trial Imaging Product and Services Table 56. Bioclinica Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025) & (USD Million) Table 57. Bioclinica Recent Developments/Updates Table 58. Bioclinica Competitive Strengths & Weaknesses Table 59. Parexel Basic Information, Manufacturing Base and Competitors Table 60. Parexel Major Business Table 61. Parexel Clinical Trial Imaging Product and Services Table 62. Parexel Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025) & (USD Million) Table 63. Parexel Recent Developments/Updates Table 64. Parexel Competitive Strengths & Weaknesses Table 65. BioTelemetry Basic Information, Manufacturing Base and Competitors Table 66. BioTelemetry Major Business Table 67. BioTelemetry Clinical Trial Imaging Product and Services Table 68. BioTelemetry Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025) & (USD Million) Table 69. BioTelemetry Recent Developments/Updates Table 70. BioTelemetry Competitive Strengths & Weaknesses Table 71. ProScan Imaging Basic Information, Manufacturing Base and Competitors Table 72. ProScan Imaging Major Business Table 73. ProScan Imaging Clinical Trial Imaging Product and Services Table 74. ProScan Imaging Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025) & (USD Million) Table 75. ProScan Imaging Recent Developments/Updates Table 76. ProScan Imaging Competitive Strengths & Weaknesses Table 77. Imaging Endpoints Basic Information, Manufacturing Base and Competitors Table 78. Imaging Endpoints Major Business Table 79. Imaging Endpoints Clinical Trial Imaging Product and Services Table 80. Imaging Endpoints Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025) & (USD Million) Table 81. Imaging Endpoints Recent Developments/Updates Table 82. Imaging Endpoints Competitive Strengths & Weaknesses Table 83. Radiant Sage Basic Information, Manufacturing Base and Competitors Table 84. Radiant Sage Major Business Table 85. Radiant Sage Clinical Trial Imaging Product and Services Table 86. Radiant Sage Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025) & (USD Million) Table 87. Radiant Sage Recent Developments/Updates Table 88. Radiant Sage Competitive Strengths & Weaknesses Table 89. Micron, Inc. Basic Information, Manufacturing Base and Competitors Table 90. Micron, Inc. Major Business Table 91. Micron, Inc. Clinical Trial Imaging Product and Services Table 92. Micron, Inc. Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025) & (USD Million) Table 93. Micron, Inc. Recent Developments/Updates Table 94. Micron, Inc. Competitive Strengths & Weaknesses Table 95. Intrinsic Imaging Basic Information, Manufacturing Base and Competitors Table 96. Intrinsic Imaging Major Business Table 97. Intrinsic Imaging Clinical Trial Imaging Product and Services Table 98. Intrinsic Imaging Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025) & (USD Million) Table 99. Intrinsic Imaging Recent Developments/Updates Table 100. Intrinsic Imaging Competitive Strengths & Weaknesses Table 101. Median Technologies Basic Information, Manufacturing Base and Competitors Table 102. Median Technologies Major Business Table 103. Median Technologies Clinical Trial Imaging Product and Services Table 104. Median Technologies Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025) & (USD Million) Table 105. Median Technologies Recent Developments/Updates Table 106. Median Technologies Competitive Strengths & Weaknesses Table 107. Cardiovascular Imaging Technologies Basic Information, Manufacturing Base and Competitors Table 108. Cardiovascular Imaging Technologies Major Business Table 109. Cardiovascular Imaging Technologies Clinical Trial Imaging Product and Services Table 110. Cardiovascular Imaging Technologies Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025) & (USD Million) Table 111. Cardiovascular Imaging Technologies Recent Developments/Updates Table 112. Cardiovascular Imaging Technologies Competitive Strengths & Weaknesses Table 113. Banook Medical Basic Information, Manufacturing Base and Competitors Table 114. Banook Medical Major Business Table 115. Banook Medical Clinical Trial Imaging Product and Services Table 116. Banook Medical Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025) & (USD Million) Table 117. Banook Medical Recent Developments/Updates Table 118. Banook Medical Competitive Strengths & Weaknesses Table 119. IXICO Basic Information, Manufacturing Base and Competitors Table 120. IXICO Major Business Table 121. IXICO Clinical Trial Imaging Product and Services Table 122. IXICO Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025) & (USD Million) Table 123. IXICO Recent Developments/Updates Table 124. IXICO Competitive Strengths & Weaknesses Table 125. Tigermed Basic Information, Manufacturing Base and Competitors Table 126. Tigermed Major Business Table 127. Tigermed Clinical Trial Imaging Product and Services Table 128. Tigermed Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025) & (USD Million) Table 129. Tigermed Recent Developments/Updates Table 130. Tigermed Competitive Strengths & Weaknesses Table 131. Runda Medical Basic Information, Manufacturing Base and Competitors Table 132. Runda Medical Major Business Table 133. Runda Medical Clinical Trial Imaging Product and Services Table 134. Runda Medical Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025) & (USD Million) Table 135. Runda Medical Recent Developments/Updates Table 136. Runda Medical Competitive Strengths & Weaknesses Table 137. Konica Minolta Basic Information, Manufacturing Base and Competitors Table 138. Konica Minolta Major Business Table 139. Konica Minolta Clinical Trial Imaging Product and Services Table 140. Konica Minolta Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025) & (USD Million) Table 141. Konica Minolta Recent Developments/Updates Table 142. Konica Minolta Competitive Strengths & Weaknesses Table 143. Keosys Basic Information, Manufacturing Base and Competitors Table 144. Keosys Major Business Table 145. Keosys Clinical Trial Imaging Product and Services Table 146. Keosys Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025) & (USD Million) Table 147. Keosys Recent Developments/Updates Table 148. Keosys Competitive Strengths & Weaknesses Table 149. Global Key Players of Clinical Trial Imaging Upstream (Raw Materials) Table 150. Global Clinical Trial Imaging Typical Customers List of Figures Figure 1. Clinical Trial Imaging Picture Figure 2. World Clinical Trial Imaging Total Revenue: 2020 & 2024 & 2031, (USD Million) Figure 3. World Clinical Trial Imaging Total Revenue (2020-2031) & (USD Million) Figure 4. World Clinical Trial Imaging Revenue by Region (2020, 2024 and 2031) & (USD Million), (by Headquarter Location) Figure 5. World Clinical Trial Imaging Revenue Market Share by Region (2020-2031), (by Headquarter Location) Figure 6. United States Based Company Clinical Trial Imaging Revenue (2020-2031) & (USD Million) Figure 7. China Based Company Clinical Trial Imaging Revenue (2020-2031) & (USD Million) Figure 8. Europe Based Company Clinical Trial Imaging Revenue (2020-2031) & (USD Million) Figure 9. Japan Based Company Clinical Trial Imaging Revenue (2020-2031) & (USD Million) Figure 10. South Korea Based Company Clinical Trial Imaging Revenue (2020-2031) & (USD Million) Figure 11. ASEAN Based Company Clinical Trial Imaging Revenue (2020-2031) & (USD Million) Figure 12. India Based Company Clinical Trial Imaging Revenue (2020-2031) & (USD Million) Figure 13. Clinical Trial Imaging Market Drivers Figure 14. Factors Affecting Demand Figure 15. World Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million) Figure 16. World Clinical Trial Imaging Consumption Value Market Share by Region (2020-2031) Figure 17. United States Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million) Figure 18. China Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million) Figure 19. Europe Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million) Figure 20. Japan Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million) Figure 21. South Korea Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million) Figure 22. ASEAN Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million) Figure 23. India Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million) Figure 24. Producer Shipments of Clinical Trial Imaging by Player Revenue ($MM) and Market Share (%): 2024 Figure 25. Global Four-firm Concentration Ratios (CR4) for Clinical Trial Imaging Markets in 2024 Figure 26. Global Four-firm Concentration Ratios (CR8) for Clinical Trial Imaging Markets in 2024 Figure 27. United States VS China: Clinical Trial Imaging Revenue Market Share Comparison (2020 & 2024 & 2031) Figure 28. United States VS China: Clinical Trial Imaging Consumption Value Market Share Comparison (2020 & 2024 & 2031) Figure 29. World Clinical Trial Imaging Market Size by Type, (USD Million), 2020 & 2024 & 2031 Figure 30. World Clinical Trial Imaging Market Size Market Share by Type in 2024 Figure 31. In-house Imaging Service Figure 32. Central Imaging Service Figure 33. World Clinical Trial Imaging Market Size Market Share by Type (2020-2031) Figure 34. World Clinical Trial Imaging Market Size by Application, (USD Million), 2020 & 2024 & 2031 Figure 35. World Clinical Trial Imaging Market Size Market Share by Application in 2024 Figure 36. Pharmaceutical Companies Figure 37. Biotechnology Companies Figure 38. Academic Institutes Figure 39. Others Figure 40. World Clinical Trial Imaging Market Size Market Share by Application (2020-2031) Figure 41. Clinical Trial Imaging Industrial Chain Figure 42. Methodology Figure 43. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.
Validation and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
ICON ERT McLaren Bioclinica Parexel BioTelemetry ProScan Imaging Imaging Endpoints Radiant Sage Micron, Inc. Intrinsic Imaging Median Technologies Cardiovascular Imaging Technologies Banook Medical IXICO Tigermed Runda Medical Konica Minolta Keosys
Related Reports
18 Jan 2025
Service & Software
Purchase Options
Add To Cart
Buy Now
- Digging deeper into global industry information and providing market strategies.Contact Us >>
